Our Hospital Partners

Sound Clinical Investment

For Your Patients

The benefits of Robotic Magnetic Navigation (RMN) have been demonstrated extensively in the real world experience of hundreds of physicians at over one hundred leading hospitals globally. They have also been demonstrated with scientific rigor in hundreds of peer-reviewed publications. We encourage you to review the clinical data detailing the reduced safety risks and improved care patients receive when being treated with RMN.

Sound Financial Investment

For Your Business

Grow Your Practice

Cardiac Arrhythmias are an epidemic.1 Ablation has emerged as a highly viable therapy for arrhythmias and has seen rapid, global adoption. Yet many patients remain untreated, particularly those with ventricular arrhythmias or congenital disease, due to the risk and technical difficulty of traditional procedures. RMN has successfully enabled many hospitals and physicians to grow their practices by taking on difficult procedures that others avoid.

Increase Efficiency

Complex cardiac ablation can take many hours to perform. The benefits of robotic precision, stability, and automation are pronounced in the most complicated procedures. Clinical literature shows meaningful reduction in procedure time and improvements in lab efficiency when using robotics.2

Reduce Risk

The body of evidence demonstrating reduction of adverse events when using RMN is robust. We encourage you to review it in detail. Similarly, the interventional lab is a dangerous place for physicians, nurses, and staff. Daily radiation exposure leads to increases in cancer. Wearing protective lead vests has caused orthopedic injury in 49% of interventional physicians as a direct result of their time in the interventional lab.3 In a robotic procedure, however, the physician and staff operate in a control room protected from radiation.

Sound Strategic Investment

For Your Institution

Differentiation in the competitive healthcare industry is critical to attracting patients, recruiting medical talent, developing robust referral networks and negotiating with payors. Adopting cutting-edge robotic technology provides that competitive differentiation while advancing clinical care, reducing occupational risk, and fueling practice growth.

Investment Calculator

Estimate the Impact of Robotic Magnetic Navigation

Use our investment calculator to estimate the potential impact of incorporating robotics into your electrophysiology program.

Contact us for a comprehensive summary of the potential impact RMN could have in your institution.

Hospital Partner Locator

Robotic EP Practices

Hospitals that adopt cutting-edge robotic technology can showcase their clinical and technological leadership in their community. Our hospital partners have access to a toolkit of educational & media resources to grow their cardiac centers of excellence.

  1. Lip GYH, Kakar P, Watson T. Atrial fibrillation—the growing epidemic. Heart. 2007;93(5):542–543.
  1. Turagam MK, Atkins D, Tung R, Mansour M, Ruskin J, Cheng J, Di Biase L, Natale A, Lakkireddy D. A meta-analysis of manual versus remote magnetic navigation for ventricular tachycardia ablation. J Interv Card Electrophysiol. 2017;49(3):227-235.
  1. Klein LW, Tra Y, Garratt KN, Powell W, Lopez-Cruz G, Chambers C, et al. Occupational health hazards of interventional cardiologists in the current decade: Results of the 2014 SCAI membership survey. Catheter Cardiovasc Interv. 2015;86(5):913-24.

Stereotaxis Intended Use Statements, United States Labeling:

The Niobe™ ES system is intended to navigate compatible magnetic devices through tissue to designated target sites in the right and left heart, coronary vasculature, neurovasculature, and peripheral vasculature by orienting the device tip in a desired direction. The Stereotaxis Cardiodrive™ automated catheter advancement system (CAS) is intended for automatically advancing and retracting only compatible magnetic electrophysiology (EP) mapping and ablation catheters inside the patient’s heart when used in conjunction with a Stereotaxis magnetic navigation system. The Cardiodrive™ system is not intended to advance the EP mapping and ablation catheters through the coronary vasculature or the coronary sinus.

Consult the associated product labeling for the Indications for Use and instructions of other devices used in conjunction with Stereotaxis products.

Niobe™ and Cardiodrive™ are trademarks of Stereotaxis, Inc. registered in the United States, European Community, and Japan.

The Genesis™ Robotic Magnetic Navigation System is CE marked. While Genesis may be marketed and sold in European Union and other jurisdictions, it is not available for commercial sale in the United States.